Amalgamated Bank’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-17,519
| Closed | -$49K | – | 1751 |
|
2020
Q1 | $49K | Sell |
17,519
-365
| -2% | -$1.02K | ﹤0.01% | 1569 |
|
2019
Q4 | $58K | Buy |
17,884
+665
| +4% | +$2.16K | ﹤0.01% | 1781 |
|
2019
Q3 | $37K | Sell |
17,219
-142
| -0.8% | -$305 | ﹤0.01% | 1737 |
|
2019
Q2 | $55K | Sell |
17,361
-3,373
| -16% | -$10.7K | ﹤0.01% | 1741 |
|
2019
Q1 | $77K | Buy |
20,734
+748
| +4% | +$2.78K | ﹤0.01% | 1618 |
|
2018
Q4 | $58K | Hold |
19,986
| – | – | ﹤0.01% | 1554 |
|
2018
Q3 | $53K | Sell |
19,986
-528
| -3% | -$1.4K | ﹤0.01% | 1419 |
|
2018
Q2 | $48K | Buy |
20,514
+546
| +3% | +$1.28K | ﹤0.01% | 1707 |
|
2018
Q1 | $59K | Sell |
19,968
-593
| -3% | -$1.75K | ﹤0.01% | 1560 |
|
2017
Q4 | $56K | Buy |
20,561
+794
| +4% | +$2.16K | ﹤0.01% | 1605 |
|
2017
Q3 | $67K | Sell |
19,767
-432
| -2% | -$1.46K | ﹤0.01% | 1533 |
|
2017
Q2 | $50K | Sell |
20,199
-553
| -3% | -$1.37K | ﹤0.01% | 1546 |
|
2017
Q1 | $47K | Buy |
20,752
+15
| +0.1% | +$34 | ﹤0.01% | 1473 |
|
2016
Q4 | $44K | Buy |
20,737
+2,647
| +15% | +$5.62K | ﹤0.01% | 1486 |
|
2016
Q3 | $61K | Buy |
18,090
+59
| +0.3% | +$199 | ﹤0.01% | 1356 |
|
2016
Q2 | $53K | Buy |
18,031
+376
| +2% | +$1.11K | ﹤0.01% | 1354 |
|
2016
Q1 | $59K | Buy |
17,655
+1,707
| +11% | +$5.71K | 0.01% | 1252 |
|
2015
Q4 | $56K | Sell |
15,948
-1,202
| -7% | -$4.22K | 0.01% | 1170 |
|
2015
Q3 | $86K | Buy |
17,150
+217
| +1% | +$1.09K | 0.01% | 1244 |
|
2015
Q2 | $109K | Buy |
16,933
+624
| +4% | +$4.02K | 0.01% | 1298 |
|
2015
Q1 | $115K | Buy |
16,309
+626
| +4% | +$4.41K | 0.01% | 904 |
|
2014
Q4 | $121K | Buy |
15,683
+22
| +0.1% | +$170 | 0.02% | 827 |
|
2014
Q3 | $117K | Sell |
15,661
-8
| -0.1% | -$60 | 0.02% | 813 |
|
2014
Q2 | $152K | Sell |
15,669
-809
| -5% | -$7.85K | 0.02% | 835 |
|
2014
Q1 | $137K | Buy |
16,478
+1,955
| +13% | +$16.3K | 0.02% | 790 |
|
2013
Q4 | $123K | Buy |
+14,523
| New | +$123K | 0.02% | 796 |
|